Tiny Messengers, Huge Consequences: Extracellular Vesicles and mTOR Signaling in Neuroinflammation

P Garcia-Segura1, A Chicote-González1, A Espasa-Marco1

  • 1Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Institut de Neurociències, Universitat de Barcelona, Barcelona, Catalonia, Spain.

PubMed

Insights

The mechanistic target of rapamycin (mTOR) pathway and extracellular vesicles (EVs) interact bidirectionally, influencing neuroinflammation in the central nervous system (CNS). This complex relationship can promote neuroprotection or exacerbate neurodegeneration.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • Neuroinflammation is a key factor in neurodegenerative diseases.
  • The mechanistic target of rapamycin (mTOR) pathway and extracellular vesicles (EVs) are critical regulators of cellular processes in the central nervous system (CNS).

Purpose of the Study:

  • To review the bidirectional interactions between mTOR signaling and EVs in the CNS.
  • To elucidate the roles of this interaction in cellular communication, inflammation, and neurodegeneration.

Main Methods:

  • Literature review focusing on studies investigating mTOR and EVs in the CNS.
  • Analysis of the regulatory mechanisms governing EV biogenesis, cargo loading, and target cell modulation by mTOR.
  • Examination of how EVs influence mTOR activity in recipient cells.

Main Results:

  • mTOR signaling regulates the production and content of EVs.
  • EVs modulate mTOR activity in target cells, affecting neuronal survival and glial activation.
  • A feedback loop exists between mTOR and EVs, influencing inflammatory responses and neurotoxicity.

Conclusions:

  • The interplay between mTOR and EVs is a crucial determinant of neuroinflammation and neurodegenerative disease progression.
  • Targeting the mTOR-EV axis offers potential therapeutic strategies for CNS disorders.
  • Understanding this bidirectional communication is vital for developing effective treatments for neurodegenerative conditions.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.5K